Bloodstream infection and occlusion of central venous catheters in children

No Thumbnail Available
File version
Author(s)
Rickard, Claire M
Ullman, Amanda J
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2018
Size
File type(s)
Location
License
Abstract

One in ten children with a central venous catheter (CVC) develops a central line-associated bloodstream infection (CLABSI),1 which is a life-threatening complication and harmful distraction from time-sensitive treatment. However, across CVC types (figure), device occlusion is also troublesome and might increase CLABSI risk, presumably through the complementary interactions of fibrin, thrombus, and biofilms.2 The question arises as to what antimicrobial, antithrombotic, or other solution can be periodically instilled (known as locked) within the CVC to prevent one, or preferably both, of these complications. Furthermore, which solutions could effectively treat such complications, should they arise, without needing to remove the CVC? Few high-quality randomised controlled trials have addressed these questions, and it is difficult to find two health-care institutions that share identical policies for lock solution type, concentration, frequency, or duration of dwell. This situation has probably resulted in preventable injuries in children who rely on CVCs to administer treatment.

Journal Title
The Lancet Infectious Diseases
Conference Title
Book Title
Edition
Volume
18
Issue
8
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Medical microbiology
Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
Persistent link to this record
Citation
Rickard, CM; Ullman, AJ, Bloodstream infection and occlusion of central venous catheters in children, The Lancet Infectious Diseases, 2018, 18 (8), pp. 815-817
Collections